Prognostic Score predicting overall survival of Patients with Intermediate Stage of Hepatocellular Carcinoma after Transarterial Chemoembolization

被引：0
|
作者：
Jarupongprapa, Saharat [1 ]
Nimanong, Supot [1 ]
Chainuvati, Siwaporn [1 ]
Charatcharoenwitthaya, Phunchai [1 ]
Tanwandee, Tawesak [1 ]
Chotiyaputta, Watcharasak [1 ]
机构：
[1] Mahidol Univ, Siriraj Hosp, Internal Med, Gastroenterol, Bangkok 10700, Thailand
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
467
引用
收藏
页码：444A / 445A
页数：2
相关论文
共 50 条
  • [41] Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma
    Labeur, Tim A.
    Takkenberg, R. Bart
    Klumpen, Heinz-Josef
    van Delden, Otto M.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 42 (02) : 230 - 238
  • [42] Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma
    Tim A. Labeur
    R. Bart Takkenberg
    Heinz-Josef Klümpen
    Otto M. van Delden
    CardioVascular and Interventional Radiology, 2019, 42 : 230 - 238
  • [43] Reason of Discontinuation after Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma
    Labeur, Tim
    Takkenberg, Bart
    Klumpen, Heinz-Josef
    Van Delden, Otto
    HEPATOLOGY, 2018, 68 : 840A - 841A
  • [44] The Impact of Combined Transarterial Chemoembolization on the Overall Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
    Chen, Lufeng
    Su, Hongying
    Shao, Haibo
    Xu, Ke
    Liang, Songnian
    Liu, Ling
    HEPATO-GASTROENTEROLOGY, 2014, 61 (131) : 802 - 808
  • [45] Prognostic factors of hepatocellular carcinoma patients treated by transarterial chemoembolization
    Xiao, Jun
    Li, Guojian
    Lin, Shuhan
    He, Ke
    Lai, Hao
    Mo, Xianwei
    Chen, Jiansi
    Lin, Yuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (03): : 1114 - 1123
  • [46] Tumor burden score as a new prognostic marker for patients with hepatocellular carcinoma undergoing transarterial chemoembolization
    Ho, Shu-Yein
    Liu, Po-Hong
    Hsu, Chia-Yang
    Ko, Chih-Chieh
    Huang, Yi-Hsiang
    Su, Chien-Wei
    Lee, Rheun-Chuan
    Tsai, Ping-Hsing
    Hou, Ming-Chih
    Huo, Teh-Ia
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (11) : 3196 - 3203
  • [47] "Six-and-Twelve" Prognostic Score in Transarterial Chemoembolization-Treated Hepatocellular Carcinoma Patients
    Valle, Johan S. Lopera
    Correa, Daniel F. Puello
    Sanin, Emilio
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [48] TUMOR BURDEN SCORE AS A NEW PROGNOSTIC MARKER FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING TRANSARTERIAL CHEMOEMBOLIZATION
    Ho, Shu-Yein
    Ko, Chih-Chieh
    Su, Chien-Wei
    Huo, Teh-Ia
    GUT, 2021, 70 : A75 - A76
  • [49] Novel Prognostic Nomogram to Predict Progression-Free Survival of Patients with Hepatocellular Carcinoma After Transarterial Chemoembolization
    Xi, Dong
    Xu, Mengying
    Han, Meiwen
    Guan, Qianting
    Guo, Qinghao
    Yan, Fangfei
    Yao, Junxia
    Ning, Qin
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 909 - 920
  • [50] Intermediate stage hepatocellular carcinoma: Comparison of the value of inflammation-based scores in predicting progression-free survival of patients receiving transarterial chemoembolization
    Liu, Ying
    Shi, Menting
    Chen, Shuanggang
    Wan, Weiqi
    Shen, Lujun
    Shen, Binyan
    Qi, Han
    Cao, Fei
    Wu, Ying
    Huang, Tao
    Chen, Guanjian
    Mo, Jinqing
    Ye, Dongdong
    Zhang, Yinqi
    Feng, Ziqing
    Fan, Weijun
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (03) : 740 - 748
12345